10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026

10x Genomics, Inc., a prominent company in the life sciences sector, has scheduled its financial results for the second quarter ending June 30, 2026. The company plans to publish its earnings after the market closes on August 6, 2026. This announcement provides investors and analysts with an upcoming update on the company's financial performance for the specified period.

The company, listed on Nasdaq under the ticker TXG, specializes in advancing human health through innovative scientific tools and technologies. The upcoming earnings report will likely include key figures such as revenue, earnings per share, and guidance for future periods.

This scheduled release is part of regular corporate reporting and is expected to influence investor sentiment and trading activity in the company's shares. Market participants will be watching for the results to assess the company's growth trajectory and financial health.

As of now, no additional details about the expected financial figures or guidance have been provided. The market impact will depend on how the results compare to analyst expectations and previous performance.